ConductScience.org, home

Paper9034992

Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.

Hasegawa M and 3 others. J Rheumatol, 1997. Cited by 281 papers, by iCite.

Cite this record

ConductScience Library. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. Papers, record 9034992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9034992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
PubMed
Journal
J Rheumatol
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
281
iCite
Relative citation ratio, by iCite
6.91
iCite
Revised in PubMed
2006-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hasegawa MM
2Fujimoto MM
3Kikuchi KK
4Takehara KK

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-10Major topic
Interleukin-13Major topic
Interleukin-4Major topic
Scleroderma, SystemicMajor topic
Adolescent
Adult
Aged
Blood Sedimentation
C-Reactive Protein
Child
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by132

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.

PMIDTitleJournalYearIn PapersSource
41102323Th1 and Th2 cells in equine endometrosis and their interactions with endometrial fibroblasts.Sci Rep2025https://conductscience.org/library/papers/41102323PubMed
39210206Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review.Clin Rheumatol2024https://conductscience.org/library/papers/39210206PubMed
38577035Biomarkers in skin autoimmunity-An update on localised scleroderma.Skin Health Dis2024https://conductscience.org/library/papers/38577035PubMed
38386070Emerging therapeutic targets in systemic sclerosis.J Mol Med (Berl)2024https://conductscience.org/library/papers/38386070PubMed
38357212Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease.JID Innov2024https://conductscience.org/library/papers/38357212PubMed
38327271Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study.Front Med (Lausanne)2023https://conductscience.org/library/papers/38327271PubMed
38292323The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis.Clin Cosmet Investig Dermatol2024https://conductscience.org/library/papers/38292323PubMed
38272806Global research status of localised scleroderma reported over the period 1993-2022: A 30-year bibliometric analysis.Int Wound J2024https://conductscience.org/library/papers/38272806PubMed
38139335Synthetic Nucleic Acid Antigens in Localized Scleroderma.Int J Mol Sci2023https://conductscience.org/library/papers/38139335PubMed
38129904SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis.J Inflamm (Lond)2023https://conductscience.org/library/papers/38129904PubMed
37630981Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37630981PubMed
37603199Treatable Traits in Systemic Sclerosis.Clin Rev Allergy Immunol2023https://conductscience.org/library/papers/37603199PubMed
37392249Type 2 cytokines and scleroderma interstitial lung disease.Clin Exp Med2023https://conductscience.org/library/papers/37392249PubMed
36835506Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review.Int J Mol Sci2023https://conductscience.org/library/papers/36835506PubMed
36726987Dysregulated B cell function and disease pathogenesis in systemic sclerosis.Front Immunol2022https://conductscience.org/library/papers/36726987PubMed
36629780STAT6 suppression prevents bleomycin-induced dermal fibrosis.FASEB J2023https://conductscience.org/library/papers/36629780PubMed
36352098Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis.Nat Rev Rheumatol2022https://conductscience.org/library/papers/36352098PubMed
36063053Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis.Rheumatology (Oxford)2023https://conductscience.org/library/papers/36063053PubMed
36015084Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36015084PubMed
35997892The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases.Adv Ther2022https://conductscience.org/library/papers/35997892PubMed

See all 132 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL133596PubTator's text mininghttps://conductscience.org/library/genes/3596NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9034992

GET https://conductscience.org/api/papers/v1/9034992/cited_by?page=2